Clinical Trial Update: A Study To Evaluate Safety And Efficacy Of IV Sildenafil In The Treatment Of Neonates With Persistent Pulmonary Hypertension Of The Newborn [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and efficacy of intravenous sildenafil in neonates with persistent pulmonary hypertension; study completed with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Persistent Pulmonary Hypertension of the Newborn

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Pulmonary Hypertension, Familial Persistent, of the Newborn | Phase 3 | Status: COMPLETED | Results posted: 2020-03-25